↓ Skip to main content

The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs

Overview of attention for article published in Pharmaceutical Research, February 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
8 patents

Readers on

mendeley
199 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs
Published in
Pharmaceutical Research, February 2004
DOI 10.1023/b:pham.0000016242.48642.71
Pubmed ID
Authors

Mehran Yazdanian, Katherine Briggs, Corinne Jankovsky, Amale Hawi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 199 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Italy 1 <1%
India 1 <1%
Slovenia 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
Belgium 1 <1%
Unknown 191 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 42 21%
Student > Ph. D. Student 29 15%
Other 20 10%
Student > Bachelor 18 9%
Student > Master 17 9%
Other 32 16%
Unknown 41 21%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 59 30%
Chemistry 27 14%
Medicine and Dentistry 24 12%
Agricultural and Biological Sciences 16 8%
Engineering 6 3%
Other 22 11%
Unknown 45 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2013.
All research outputs
#5,611,796
of 25,837,817 outputs
Outputs from Pharmaceutical Research
#559
of 3,104 outputs
Outputs of similar age
#17,985
of 150,263 outputs
Outputs of similar age from Pharmaceutical Research
#7
of 32 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,104 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 150,263 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.